Welcome to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
Yes
No
NB: We use cookies to help personalise your web experience and comply with Irish healthcare law. Whatever your choice, you are agreeing to our use of cookies. Please close this browser tab if you don't want to proceed.
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

May 26, 2016

Testing should be ‘a shared decision’

With PSA testing, there is an increased tendency to detect prostate cancer but with time, that advantage diminishes, Gary Culliton reports in his latest Clinical Update. The need for testing in the low-risk group, is very much reduced.

Data back ‘long periods’ of therapy treatment

New data has supported the case for some patients taking abiraterone for long periods of time, Britain’s National Institute for Health and Care Excellence (NICE) has said. NICE has issued final guidance recommending abiraterone for some prostate cancer patients.

Galway research may help fight cancer

A team of researchers from the Centre for Chromosome Biology at NUI Galway, in collaboration with the IFOM Research Institute in Milan, Italy, have discovered that a protein named USP9X contributes to the efficient duplication of the DNA in cells and may help in the battle against cancer.

White blood cell ratio linked to cancer recurrence risk

A high ratio of two types of immune system cell is linked to an increased risk of disease recurrence after a diagnosis of early-stage breast cancer, finds the first study of its kind, published in the online journal ESMO Open, which could open to way for future treatment and monitoring strategies.

3D DBT better than just digital mammography

A new study of breast cancer screening, published online by JAMA Oncology, suggests 3D digital breast tomosynthesis (DBT) outcomes were sustainable with significant reduction in patient recall, increasing cancer cases per recalled patients and a decline in interval cancers.

Outcomes with new agents outlined

An individual approach to breast cancer treatment is now preferred, Gary Culliton reports in his latest Clinical Update. The way drugs are administered and scheduled is now much more specific to the type of disease involved.

Testing of BRCA1 and BRCA2 on the rise in those under-40

Rates of genetic testing for the BRCA1 and BRCA2 gene mutations have increased among women diagnosed with cancer aged 40 years and under, US research has found.

Caregiving has major financial impact

Head and neck cancer can have a serious and long-lasting financial and emotional impact, not just on the patients alone, but also on their carers who are often older and poorer, according to a new research by the National Cancer Registry (NCRI), published in the Journal of Psycho-Oncology.

Novel protein target could help find dormant cancer stem cells

A novel protein target that could help identify cancer stem cells while they are dormant has been discovered by scientists at Trinity College, Dublin.

Childhood cancer survivors are at higher risk of autoimmune diseases

Childhood cancer survivors are at heightened risk of a wide range of autoimmune diseases, reveals research published online in the Annals of the Rheumatic Diseases, with diabetes and Addison’s disease making up almost half of the excess cases.

« Previous Page
Next Page »